Sector
PharmaceuticalsOpen
₹13.32Prev. Close
₹14.8Turnover(Lac.)
₹2.13Day's High
₹13.32Day's Low
₹13.3252 Week's High
₹27.152 Week's Low
₹9.25Book Value
₹13.45Face Value
₹10Mkt Cap (₹ Cr.)
6.44P/E
83.25EPS
0.16Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 5.46 | 4.06 | 4.06 | 4.06 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.59 | 1.39 | 1.35 | 1.31 |
Net Worth | 7.05 | 5.45 | 5.41 | 5.37 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 2.37 | 3.07 | 3.05 | 3.01 |
yoy growth (%) | -22.88 | 0.85 | 1.4 | 14.51 |
Raw materials | -1.23 | -1.27 | -1.15 | -1.06 |
As % of sales | 52.08 | 41.48 | 37.97 | 35.31 |
Employee costs | -0.42 | -0.43 | -0.43 | -0.33 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 0.03 | 0.25 | 0.12 | 0.1 |
Depreciation | -0.05 | -0.05 | -0.05 | -0.04 |
Tax paid | -0.01 | -0.06 | -0.03 | -0.03 |
Working capital | 0.35 | 0.27 | -0.22 | -0.59 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -22.88 | 0.85 | 1.4 | 14.51 |
Op profit growth | -91.96 | 21.96 | 2.83 | 1.79 |
EBIT growth | -53.42 | 23.04 | -4.42 | 6.8 |
Net profit growth | -89.21 | 100.78 | 26.76 | 52.37 |
Particulars (Rupees in Crores.) | Mar-2021 | Mar-2020 |
---|---|---|
Gross Sales | 2.37 | 3.08 |
Excise Duty | 0 | 0 |
Net Sales | 2.37 | 3.08 |
Other Operating Income | 0 | 0 |
Other Income | 0.25 | 0.17 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
SANJAY VYANKATESH KULKARNI
Managing Director & CEO
BHARAT BRIJMOHAN SHARMA
Whole-time Director
SRIJNA SHARMA
Independent Director
SACHIN CHANDRAKANT CHAVAN
Independent Director
CHETAN BHIKHUBHAI PATEL
Additional Director
Aman Mukesh Chaudhari.
Additional Director
Munna Baijnath Chaurasia
Gangatat Dhanvantri Marg,
Gopcharpada Virar (E),
Maharashtra - 401305
Tel: 91-250-6098333/444
Website: http://www.ayurvedganga.com
Email: ayurvedganga@gmail.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Ganga Pharmaceuticals Ltd was incorporated as a Public Limited Company in Aug.94 and promoted by Brij Mohan Sharma. he Company is engaged in the business of manufacturing & trading in Pharmaceuticals ...
Read More
Reports by Ganga Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.